Acute Respiratory DistressNCT06578377
The Epidemiology of Acute Respiratory Distress Among Children, A Retrospective Cross-Sectional Study
An observational study of Acute Respiratory Distress, run by Mofid Children Hospital at 1 site in Iran.
Trial summary
l Respiratory distress is still a major concern in pediatric medicine. l In this study we evaluated the symptoms and causes of respiratory distress among children in a tertiary hospital. l We found that tachypnea is the most common symptom and asthma is the most common cause of respiratory distress in children. Read more about this study
- Who is it for?
- Ages 1 month to 18 years
- Conditions the study is for
- Acute Respiratory Distress
- What is being tested?
- descriptive study
- How many people
- 154 participants
- Where
- 1 siteIran
- Study dates
- 1 Oct 2018to 30 Dec 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 month to 18 years
- All sexes
- Child, Adult
Study population: From a total of 186 patients who visited the emergency room of Mofid Children's Hospital during the period of the study, 154 included in the study
Who may be able to join
- patients older than one month
- signs or symptoms of respiratory distress, including tachypnea, bradypnea, cyanosis, respiratory muscle retraction, nasal flaring, tachycardia, and bradycardia
Who cannot join
- Patients older than 18 years old
- apnea
- known cardiac diseases
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Epidemiology of Acute Respiratory Distress Among Children, A Retrospective Cross-Sectional Study From Iran
l Respiratory distress is still a major concern in pediatric medicine. l In this study we evaluated the symptoms and causes of respiratory distress among children in a tertiary hospital.
l We found that tachypnea is the most common symptom and asthma is the most common cause of respiratory distress in children.
- Conditions
- Acute Respiratory Distress
- Being tested
- descriptive study
- Medical subject headings
- Acute Lung Injury
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
descriptive studyOther
It is a descriptive study
What is being measured
The primary outcome is the main question the study is designed to answer.
The most common symptom
Measured: six months
The most common cause of respiratory distress
Measured: six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2024
- Study start1 Oct 2018
- Primary completion30 Apr 2019
- Study completion30 Dec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Respiratory DistressStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Retrospective
- Enrolment
- 154 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mofid Children Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Dr Fatemeh Shojaeian, Dr seyed mohamadsadegh mousavi-kiasary, Dr Samira Sayyah
- Responsible party
- Principal investigator, Mahdis Bayat, Mofid Children Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06578377
- Sponsor's protocol ID
- MofidCH
- Status last verified
- Aug 2024
- First submitted
- 26 Aug 2024
- Last updated
- 29 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Epidemiology of Acute Respiratory Distress Among Children, A Retrospective Cross-Sectional Study From Iran
- ClinicalTrials.gov ID
- NCT06578377
- Acronym / sponsor ID
- MofidCH
- Conditions
- Acute Respiratory Distress
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 154 participants (actual)
- Lead sponsor
- Mofid Children HospitalUniversity, hospital or other
- Collaborators
- Dr Fatemeh Shojaeian, Dr seyed mohamadsadegh mousavi-kiasary, Dr Samira Sayyah
- Study start
- 1 Oct 2018 (actual)
- Primary completion
- 30 Apr 2019 (actual)
- Study completion
- 30 Dec 2019 (actual)
- First posted
- 29 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
l Respiratory distress is still a major concern in pediatric medicine. l In this study we evaluated the symptoms and causes of respiratory distress among children in a tertiary hospital.
l We found that tachypnea is the most common symptom and asthma is the most common cause of respiratory distress in children.
Study design
- Observational model
- Case crossover
- Time perspective
- Retrospective
Who may qualify
- Ages
- 1 month to 18 years
- Sex
- All
- Age groups
- Child, Adult
- Study population
- From a total of 186 patients who visited the emergency room of Mofid Children's Hospital during the period of the study, 154 included in the study
Key inclusion criteria (2 listed)
- patients older than one month
- signs or symptoms of respiratory distress, including tachypnea, bradypnea, cyanosis, respiratory muscle retraction, nasal flaring, tachycardia, and bradycardia
Key exclusion criteria (3 listed)
- Patients older than 18 years old
- apnea
- known cardiac diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| descriptive studyIt is a descriptive study | Other | – |
Primary outcome
The most common symptom
Time frame: six months
The most common cause of respiratory distress
Time frame: six months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Aug 2024.
- Individual participant dataSharing planned: No
Related trials for Acute Respiratory Distress
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not yet recruitingObservational study
Development and Multicenter Validation of an Explainable System for Neonatal ARDS-Compatible Phenotyping
Acute Respiratory Distress Syndrome
RecruitingObservational study
Assessment of Blood Viscosity in ARDS (Acute Respiratory Distress Syndrome)
ARDS
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
RecruitingObservational study
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Respiratory Distress, run by Mofid Children Hospital at 1 site in Iran.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The most common symptom (time frame: six months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2024.